AstraZeneca PLC (AZN)
175.29
-0.12
(-0.07%)
USD |
NYSE |
Nov 20, 15:17
AstraZeneca 30-Day Average Daily Volume : 2.972M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.972M |
| November 18, 2026 | 3.002M |
| November 17, 2026 | 2.999M |
| November 16, 2026 | 2.989M |
| November 13, 2026 | 2.999M |
| November 12, 2026 | 3.038M |
| November 11, 2026 | 3.094M |
| November 10, 2026 | 3.120M |
| November 09, 2026 | 3.173M |
| November 06, 2026 | 3.149M |
| November 05, 2026 | 3.123M |
| November 04, 2026 | 3.068M |
| November 03, 2026 | 2.995M |
| November 02, 2026 | 2.943M |
| October 30, 2026 | 2.950M |
| October 29, 2026 | 2.870M |
| October 28, 2026 | 2.873M |
| October 27, 2026 | 2.945M |
| October 26, 2026 | 2.947M |
| October 23, 2026 | 2.939M |
| October 22, 2026 | 2.891M |
| October 21, 2026 | 2.896M |
| October 20, 2026 | 2.962M |
| October 19, 2026 | 2.980M |
| October 16, 2026 | 3.005M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.971M |
| October 14, 2026 | 2.934M |
| October 13, 2026 | 2.910M |
| October 12, 2026 | 2.908M |
| October 09, 2026 | 2.909M |
| October 08, 2026 | 2.921M |
| October 07, 2026 | 2.894M |
| October 06, 2026 | 2.928M |
| October 05, 2026 | 2.952M |
| October 02, 2026 | 2.983M |
| October 01, 2026 | 3.051M |
| September 30, 2026 | 3.066M |
| September 29, 2026 | 3.092M |
| September 28, 2026 | 3.092M |
| September 25, 2026 | 3.157M |
| September 24, 2026 | 3.208M |
| September 23, 2026 | 3.240M |
| September 22, 2026 | 3.253M |
| September 21, 2026 | 3.301M |
| September 18, 2026 | 3.327M |
| September 17, 2026 | 3.304M |
| September 16, 2026 | 3.410M |
| September 15, 2026 | 3.551M |
| September 14, 2026 | 3.997M |
| September 11, 2026 | 3.950M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| GSK Plc | 4.556M |
| Johnson & Johnson | 7.928M |
| Eli Lilly & Co. | 2.850M |
| Merck & Co., Inc. | 9.760M |
| Novo Nordisk A/S | 11.97M |